![]() Taiwan Liposome Taiwan Liposome is a pharmaceutical company dedicated to the development and commercialization of novel nanomedicines that combine its proprietary lipid-assembled drug delivery platform with approved active pharmaceutical ingredients (APIs). | |||
Founding Date | Founding Date 2008 | Founding Date 2014 | Founding Date 1997 |
Type | Type Private | Type Public | Type Private |
Tags | |||
Locations | Locations Basel, CH HQ Lille, FR | Locations London, GB HQ Basel, CH Boston, US New York, US | Locations Taipei, TW HQ 港区, JP Leiden, NL South San Francisco, US |
Employees | Employees 294% increase | Employees 908 | Employees 1652% decrease |
Financial | |||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $8.3m (FY, 2025) | Revenue (est.) NT$101.9m (FY, 2020) |
Net income | Net income N/A | Net income ($397.9m) (FY, 2025) | Net income (NT$983.3m) (FY, 2020) |
Funding | |||
Total funding raised | Total funding raised $ 37.7m | Total funding raised $ 1.9b | Total funding raised N/A |

Roivant Sciences is a company that develops and commercializes medicines.
View company
Taiwan Liposome is a pharmaceutical company dedicated to the development and commercialization of novel nanomedicines that combine its proprietary lipid-assembled drug delivery platform with approved active pharmaceutical ingredients (APIs).
View company